ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,790, issued on Oct. 14, was assigned to MONASH UNIVERSITY (Clayton, Australia).

"Binding proteins to the human thrombin receptor, PAR4" was invented by Justin Hamilton (Clayton, Australia) and Mark Sleeman (Clayton, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to human protease activated receptor 4 (PAR4) binding proteins (e.g. antibodies). In particular, anti-PAR4 binding proteins which are antagonists of human PAR4, as well as methods and uses thereof."

The patent was filed on Aug. 30, 2023, under Application No. 18/240,347.

*For further information, including images, charts and tables, please visit...